CD36 and Obesity: Our recent study revealed that VAT from obese mice inhibits endothelial Kir2.1 function in a CD36-dependent manner, suggesting the VAT/CD36/Kir2.1 axis is a potential contributor to obesity-induced endothelial dysfunction [19].